Merck and Intercell terminate Phase II/III clinical trial of V710
8 June 2011 | By Merck
DMC recommends termination of the evaluation of investigational Staphylococcus aureus vaccine, V710...
List view / Grid view
8 June 2011 | By Merck
DMC recommends termination of the evaluation of investigational Staphylococcus aureus vaccine, V710...
11 April 2011 | By Merck
After a pre-specified interim analysis the DMC has recommended suspension of enrollment...
20 July 2010 | By Capital MS&L
Intercell AG announced that Bill Gates, has visited Intercell's headquarter for a close look at the Company's product pipeline and...